These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13676807)

  • 1. [Effect of shock on changes of toxin-resistance of erythrocytes following passive immunization of rabbits by Clostridium perfringens anti-gangrene serum].
    SINADSKII NE
    Zh Mikrobiol Epidemiol Immunobiol; 1959 May; 30(5):99-102. PubMed ID: 13676807
    [No Abstract]   [Full Text] [Related]  

  • 2. Stress proteins of Clostridium perfringens type A immunoreact with antiserum from rabbits infected with gas gangrene.
    Heredia N; Aréchiga E; Labbé R; García S
    Int Microbiol; 2003 Dec; 6(4):259-61. PubMed ID: 12910385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [QUANTITATIVE DETERMINATION OF CL. WELCHII TOXIN IN THE BLOOD IN GAS GANGRENE].
    SINADSKY N
    Zentralbl Chir; 1964 Mar; 89():388-91. PubMed ID: 14186585
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morphological erythrocyte changes due to alpha and theta hemolysin due to gas gangrene toxin].
    HABERMANN E; POHLMANN G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1959; 237():487-94. PubMed ID: 13830669
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the production of gas gangrene serum in general and of polyvalent gas gangrene aphylacto-serum of the horse especially using the simultaneous immunization method with the 4 known gas gangrene types in uno].
    Becker M
    Arch Exp Veterinarmed; 1967; 21(2):519-46. PubMed ID: 4302817
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of antitoxic and antibacterial factors in active immunization against experimental Bacillus perfringens as gangrene].
    VYGODCHIKOV GV; VOLKOVA ZM; ZELEVINSKAIA SA; LARINA Ia
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Oct; 28(10):120-5. PubMed ID: 13531900
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of antibiotics in combination with antiperfringens serum in the treatment of experimental gas infection caused by Cl. perfringens in association with Escherichia coli].
    Solov'ev SV; Matveev KI
    Eksp Khir Anesteziol; 1969; 14(1):41-3. PubMed ID: 4314241
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Gas gangrene.
    Lindsey D
    Med J Aust; 1973 Nov; 2(21):988. PubMed ID: 4358989
    [No Abstract]   [Full Text] [Related]  

  • 9. [The combined treatment of gas gangrene. IV. Histopathological lesions in experimental Clostridium perfringens infections in white mice and their normal dynamics as well as those under the influence of certain combined therapies].
    Bonciu C; Bittner J; Petrovici M; Ardeleanu J
    Arch Roum Pathol Exp Microbiol; 1966 Sep; 25(3):665-90 contd. PubMed ID: 4292258
    [No Abstract]   [Full Text] [Related]  

  • 10. Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.
    Uzal FA; McClane BA; Cheung JK; Theoret J; Garcia JP; Moore RJ; Rood JI
    Vet Microbiol; 2015 Aug; 179(1-2):23-33. PubMed ID: 25770894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The experimental validation of methods for the emergency immunoprophylaxis of gas gangrene].
    Sergeeva TI; Chirikova EV; Babaĭtseva VA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):9-13. PubMed ID: 8525744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SORPTION OF ANTITOXIC ANTIGANGRENE SERUM WITH HUMAN ERYTHROCYTES].
    SINADSKII NE
    Zh Mikrobiol Epidemiol Immunobiol; 1963 May; 40():121-3. PubMed ID: 14077123
    [No Abstract]   [Full Text] [Related]  

  • 13. [Infection of surgical wounds with Clostridium].
    Juvara I; Prişcu A; Dragomirescu C; Tătari V; Bittner J; Moinescu V
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1974; 23(8):685-94. PubMed ID: 4377678
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serotherapy of the gas gangrene].
    Lenzi G; Gritti FM; Catalini MG; Grillo A; Bonazzi L; Trenti GL; Vannini V; Zini M
    G Mal Infett Parassit; 1972 Mar; 24(3):160-81. PubMed ID: 4340520
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of a gangrene antiserum in the surgical treatment of acute paraproctitis].
    Kardasevich IA; Terent'ev GV
    Klin Khir (1962); 1978 Apr; (4):54-5. PubMed ID: 206758
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock.
    Stevens DL; Bryant AE
    Clin Infect Dis; 1997 Sep; 25 Suppl 2():S160-4. PubMed ID: 9310664
    [No Abstract]   [Full Text] [Related]  

  • 17. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene.
    Williamson ED; Titball RW
    Vaccine; 1993 Sep; 11(12):1253-8. PubMed ID: 8256506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of alpha-toxin of Clostridium perfringens and its role in the pathogenesis of gas gangrene (author's transl)].
    Murata R; Ohsaka A
    Nihon Saikingaku Zasshi; 1977 Sep; 32(5):671-89. PubMed ID: 199761
    [No Abstract]   [Full Text] [Related]  

  • 19. [STUDY OF THE ELECTROCARDIOGRAPHIC CHANGES INDUCED IN RABBITS BY LETHAL DOSES OF ALPHA TOXIN FROM CLOSTRIDIUM WELCHII].
    CASTAGNETTA E; MERUCCI P
    Rend Ist Sup Sanit; 1963; 26():1073-87. PubMed ID: 14134252
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gas gangrene. Etiologic clinical and current therapeutic aspects].
    Larcan A; Laprevote-Heully MC; Lambert H
    Nouv Presse Med; 1974 Nov 9-23; 3(38-40):2493-6. PubMed ID: 4374685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.